David Taplin Marshall MD MS
Gastrointestinal Cancer, Urologic Cancer
Chair - Department of Radiation Medicine, Medical University of South Carolina - Hollings Cancer Center
Join to View Full Profile
169 Ashley AveMSC 318Charleston, SC 29425
Phone+1 843-792-3273
Fax+1 843-792-5498
Dr. Marshall is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Marshall is a Radiation Oncologist and Chair of the Department of Radiation Medicine at the NCI-Designated Hollings Cancer Center at the Medical University of South Carolina in Charleston, SC, specializing in gastrointestinal and urologic cancers. He completed his residency in Radiation Oncology at the University of Florida and holds a medical degree from the University of Texas Southwestern Medical School. Dr. Marshall has been on staff at MUSC since 2004, focusing on brachytherapy, prostate cancer, gastrointestinal tumors, and stereotactic radiotherapy. His research contributions include published studies on cancer treatments and biomarkers, with several papers cited in the scientific community. Dr. Marshall has developed and participated in multiple clinical trials involving cancer therapies and also serves as the Medical Director of the Hollings Cancer Center Clinical Trials Office.
Clinical Expertise
- Brachytherapy, Prostate cancer, Non-melanoma skin cancer, Stereotactic radiosurgery, Clinical research, Prostate seed therapy, Radiotherapy, Gastrointesintal radiation oncology, Urologic radiation oncology, Graduate Medical Education
Education & Training
University of FloridaResidency, Radiation Oncology, 1996 - 2000
Methodist Health System DallasInternship, Surgery, 1995 - 1996
University of Texas Southwestern Medical SchoolClass of 1995
University of FloridaMS, Nuclear Engineering Sciences, Health Physics , 1989 - 1991
Texas A&M UniversityBS, Nuclear Engineering , Cum Laude, 1985 - 1989
Work Experience
MUSC Health University Medical Center (Charleston, SC)Professor · January 2004 - Current

Certifications & Licensure
SC State Medical License 2004 - 2027
FL State Medical License 1997 - 2020
NJ State Medical License 2000 - 2005
NY State Medical License 2003 - 2005
GA State Medical License 1997 - 2003
American Board of Radiology Radiation Oncology
American Board of Radiology Radiation Oncology Recertification
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer Start of enrollment: 2007 Jan 16
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Publications & Presentations
PubMed
- 1 citationsPrognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTO...Zaker Rana, Sophia C Kamran, Amol C Shetty, Philip Sutera, Yang Song
European Urology Oncology. 2024-10-01 - 3 citationsLong-Term Outcomes of a Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image Guided Intensity Modulated Radiation Therapy for Localized High-Risk Pros...Shauna McVorran, Thomas Keane, David T Marshall
Advances in Radiation Oncology. 2022-03-10 - Long-Term Outcomes of a Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image-Guided Intensity-Modulated Radiotherapy for Localized High-Risk Prostate ...S.M. McVorran, David T. Marshall
International Journal of Radiation Oncology Biology Physics. 2021-11-01
Press Mentions
Quitting Smoking After Cancer Diagnosis Can Add Years to Patient LivesOctober 31st, 2024
Partnership Between VA, Hollings Brings Cancer Clinical Trial Opportunities to VeteransAugust 19th, 2023
Grant Support
- Medical University of South Carolina NCORP Minority/Underserved Community SiteMEDICAL UNIVERSITY OF SOUTH CAROLINA2014–2026
External Links
- MUSC Radiation Oncologyhttps://medicine.musc.edu/departments/radiation-oncology
- Hollings Cancer Centerhttps://hollingscancercenter.musc.edu/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









